Trexquant Investment’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.39M Buy
90,148
+57,945
+180% +$863K 0.01% 1381
2026
Q2
$419K Sell
32,203
-25,232
-44% -$287K ﹤0.01% 1683
2026
Q1
$653K Sell
57,435
-205,644
-78% -$2.23M ﹤0.01% 1378
2025
Q4
$3.38M Buy
263,079
+10,303
+4% +$127K 0.03% 772
2025
Q3
$2.82M Sell
252,776
-105,596
-29% -$1.02M 0.03% 767
2025
Q2
$3.56M Buy
358,372
+3,306
+0.9% +$32.4K 0.04% 660
2025
Q1
$3.33M Buy
355,066
+273,295
+334% +$2.87M 0.04% 669
2024
Q4
$749K Sell
81,771
-198,494
-71% -$1.46M 0.01% 1184
2024
Q3
$2.18M Buy
280,265
+179,592
+178% +$1.3M 0.03% 777
2024
Q2
$609K Buy
100,673
+88,401
+720% +$546K 0.01% 1179
2024
Q1
$72K Sell
12,272
-128,209
-91% -$762K ﹤0.01% 1391
2023
Q4
$1.1M Sell
140,481
-47,373
-25% -$329K 0.02% 789
2023
Q3
$1.37M Buy
+187,854
New +$1.56M 0.03% 631
2023
Q2
– Sell
-80,742
Closed -$835K – 1408
2023
Q1
$835K Buy
+80,742
New +$1.03M 0.02% 806
2022
Q4
– Sell
-11,429
Closed -$234K – 1349
2022
Q3
$234K Buy
+11,429
New +$251K 0.01% 1127
2022
Q1
– Sell
-10,383
Closed -$286K – 1324
2021
Q4
$286K Sell
10,383
-7,097
-41% -$196K 0.02% 946
2021
Q3
$453K Buy
17,480
+8,180
+88% +$219K 0.04% 575
2021
Q2
$252K Sell
9,300
-15,073
-62% -$368K 0.02% 800
2021
Q1
$570K Buy
24,373
+6,666
+38% +$135K 0.05% 462
2020
Q4
$271K Sell
17,707
-1,869
-10% -$23.7K 0.03% 747
2020
Q3
$236K Buy
+19,576
New +$186K 0.02% 1017
2018
Q2
– Sell
-21,345
Closed -$368K – 880
2018
Q1
$368K Buy
+21,345
New +$356K 0.03% 736
2017
Q4
– Sell
-10,220
Closed -$175K – 1032
2017
Q3
$175K Buy
+10,220
New +$172K 0.04% 666
2017
Q2
– Sell
-20,635
Closed -$358K – 777
2017
Q1
$358K Buy
+20,635
New +$345K 0.05% 676
2016
Q4
– Sell
-10,158
Closed -$178K – 934
2016
Q3
$178K Buy
+10,158
New +$165K 0.04% 654
2015
Q2
– Sell
-29,800
Closed -$530K – 965
2015
Q1
$530K Buy
+29,800
New +$554K 0.05% 659

Other funds holding ANGO

Trexquant Investment's ANGO Position: Q3 2026 in Review

Trexquant Investment increased its AngioDynamics (ANGO) stake by 180% in Q3 2026, buying an estimated $863K and bringing the position to 90,148 shares worth $1.39M. The position accounts for 0.01% of the portfolio, ranked #1381.

Trexquant Investment first reported a position in ANGO in Q1 2015 and has held it in 26 quarters since. The position peaked at $3.56M in Q2 2025. 172 funds tracked by Wall St. Rank hold ANGO as of Q3 2026.

  • Trexquant Investment held 90,148 shares of AngioDynamics worth $1.39M as of Q3 2026.
  • Trexquant Investment bought 57,945 AngioDynamics shares in Q3 2026, an estimated $863K.
  • AngioDynamics made up 0.01% of Trexquant Investment's portfolio in Q3 2026, its #1381 holding.
  • Trexquant Investment first reported a position in AngioDynamics in Q1 2015 and has held it in 26 quarters since.
  • Trexquant Investment's AngioDynamics position peaked at $3.56M in Q2 2025.
  • 172 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2026.

Based on Trexquant Investment's 13F filing for Q3 2026, filed 16 Nov 2026.